Dr. Salimi Receives Grant to Study Vascular Growth Factor Angiopoietin 1
The Neonatal Diseases Research Program and Pediatric Critical Care fellowship has announced that Umar Salimi, MD, pediatric critical care fellow, has been awarded a $10,000 grant from the Little Giraffe Foundation for investigating the use of vascular growth factor angiopoietin 1 to treat acute and chronic lung injury in preclinical models of newborn sepsis.
Additionally, his work has been recognized by the Society of Critical Care Medicine with a Star Research award, and selection for plenary presentation at the society’s upcoming annual congress.
Dr. Salimi pursues his work in the Donald Thiebault neonatology laboratories under the primary mentorship of Venkatesh Sampath, MD, Director of the Neonatal Diseases Research program, and also critical care physicians Kato Han, MD, and Geoffrey Allen, MD, Chief, Pediatric Intensive Care.
His work has been supported by Neonatology and lab members including Heather Menden, MS; Sheng Xia, PhD; Sherry Mabry, MS; Wei Yu, PhD; Inamul Haque, PhD; Christopher Nitkin, MD; and Alain Cuna, MD.
Children’s Mercy Kansas City is ranked as one of “America's Best Children's Hospitals” in nine specialties rated by U.S. News & World Report and has received MagnetTM recognition for excellence in nursing services five consecutive times. With 386 licensed beds and a medical staff of more than 750 pediatric subspecialists, we care for children from all 50 states and from around the world. In addition, our leadership in pediatric genomic medicine and individualized pediatric therapeutics is driving research and innovation in neonatology, nephrology, endocrinology, gastroenterology, neurology, heart, cancer and other subspecialties to transform outcomes for children. Children’s Mercy also is nationally recognized for innovation in psychosocial care and creating a family-centered environment focused on the unique needs of hospitalized children and their families. Our love for children powers everything we do, inspiring our research, innovations and our everyday care. Because love has no limits. And with it, neither do we.